2021 revenue grew over four times year-over-year to $323 million Monthly revenue in January 2022 exceeded $80 million Guidance for 2022 revenue to grow again almost another three times to $900 million to $1 billion Significant operational leverage, with Adjusted EBITDA as a percentage of Total revenue improving from% in 2020 to% in 2021, and projected to.
2021 revenue grew over four times year-over-year to $323 million Monthly revenue in January 2022 exceeded $80 million Guidance for 2022 revenue to grow again almost another three times
Babylon (NYSE: BBLN) today announced completion of its acquisition of DayToDay Health ("DayToDay") to provide Babylon members with DayToDay's digital-first, highly engaging programs and clinical services